AngioDynamics, Inc. (ANGO) Capital expenditures 2017–2026
AngioDynamics, Inc. (ANGO) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$2.6MFY2026 · since FY2017: $3.0M → $2.6M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2026 | $2.6M | -42.2% |
| FY2025 | $4.5M | +77.3% |
| FY2024 | $2.5M | -33.9% |
| FY2023 | $3.8M | -11.3% |
| FY2022 | $4.3M | -17.2% |
| FY2021 | $5.2M | -28.3% |
| FY2020 | $7.2M | +132.0% |
| FY2019 | $3.1M | +30.4% |
| FY2018 | $2.4M | -20.3% |
| FY2017 | $3.0M | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice